RGEN News and Press, Repligen Corporation From 06/16/23

2023-06-16 17:39:00 ET Gainers: Kezar Life Sciences ( NASDAQ: KZR ) +6% . Telos Corporation ( TLS ) +4% . Dyne Therapeutics ( DYN ) +4% . Recursion Pharmaceuticals ( RXRX ) +4% . Berry Corporation ( BRY ) +4% . Losers: ...

2023-06-05 12:50:16 ET Summary Repligen has seen significant growth in the past decade and is well-positioned to benefit from the increasing popularity of biologics. Recent growth has been impacted by unfavorable comparability due to COVID-related revenue, but it is expected to re...

2023-06-05 12:11:00 ET Summary Repligen Corporation is facing tougher comparables with the pandemic-related revenue contribution vanishing. This is expected, but the softer organic growth in the base business is disappointing. With valuations still being demanding, I am fearfu...

2023-05-04 10:23:00 ET Summary Stocks rose on investors’ hopes that moderating inflation and certain weakening economic indicators might lead the Federal Reserve to end its cycle of interest rate increases. The Fund’s investments in the Financials, IT, Industrials, a...

2023-05-02 13:51:06 ET Repligen Corporation (NASDAQ:RGEN) Q1 2023 Earnings Conference Call May 2, 2023, 8:30 AM ET Company Participants Sondra Newman - Head, IR Tony Hunt - President and Chief Executive Officer Jon Snodgres - Chief Financial Officer Confere...

2023-05-02 07:36:22 ET Repligen press release ( NASDAQ: RGEN ): Q1 Non-GAAP EPS of $0.64 beats by $0.05 . Revenue of $182.66M (-11.5% Y/Y) beats by $1.23M . YEAR 2023 GUIDANCE: Total reported revenue is expected to be in the range of $720-$760 million v...

Reports first quarter revenue of $182.7 million, with base business growth of 4% as reported and 7% at constant currency Reports first quarter gross margin of 55.2% on both GAAP and adjusted (non-GAAP) basis Closed on acquisition of single-use bag manufacturer FlexBiosys Inc. in A...

2023-04-25 14:07:06 ET Shares of bioprocessing technology company Repligen (NASDAQ: RGEN) were down by 10% on heavy volume as of 12:42 p.m. ET Tuesday. That steep decline appears to be connected to the first-quarter earnings report of its fellow bioprocessing and lab specialist, S...

2023-04-20 10:14:49 ET Shares of Life Sciences tool makers Thermo Fisher Scientific ( TMO ), Danaher Corporation ( DHR ), Repligen ( RGEN ), and Bio-Rad Laboratories ( BIO ) came under pressure after their EU peer Sartorius ( OTCPK:SARTF ) disappointed with its Q1 2023 e...

WALTHAM, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2023 financial results on Tuesday, May 2, 2023. The Company will issue a press release before the market opens and will host a conference call at 8:...